发明名称 Hydrazide containing nuclear transport modulators and uses thereof
摘要 OF THE INVENTION The invention generally relates to nuclear transport modulators, e.g., CRM1 inhibitors, and more particularly to a compound represented by structural formula I: N-N NH / '> O N-R 2 F3C N R CF 3 (1) or a pharmaceutically acceptable salt thereof, wherein the values and alternative values for the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with CRM1 activity. (11J610033N
申请公布号 AU2016210682(A1) 申请公布日期 2016.08.18
申请号 AU20160210682 申请日期 2016.08.04
申请人 KARYOPHARM THERAPEUTICS, INC. 发明人 SANDANAYAKA, VINCENT P.;SHACHAM, SHARON;MCCAULEY, DILARA;SHECHTER, SHARON
分类号 C07D249/08;A61K31/4439;A61K31/497;A61K31/498;A61K31/506;A61K31/5377;A61K31/55;A61P27/02;A61P29/00;A61P31/12;A61P35/00;C07D401/12;C07D403/12;C07D409/12 主分类号 C07D249/08
代理机构 代理人
主权项
地址